AxoGen Q2 Revenue USD 69.7 Million Vs. IBES Estimate USD 67.1 Million
AXGN•Q2 results and outlook
Jul. 29 (Reuters) - AxoGen Q2 gross margin 72.7%.
- Q2 adjusted EBITDA USD 8.4 million
- Q2 adjusted net income USD 7.3 million
- Q2 net income USD -1.5 million
- outlook FY revenue USD 279 million vs. IBES estimate USD 270.9 million




